혁신 신약 개발 전문기업인 큐리언트(115180)는 아드릭세티닙(Adrixetinib, Q702)의 급성 골수성 백혈병(AML) 임상시험이 개시되었다고 25일 밝혔다. 이번 임상시험은 지난 6월 IND 승인을 받은 MD 앤더슨 암센터(MD Anderson Cancer Center) 주관의 임상시험으로, 재발성/불응성 급성....Article Source : 메디파나뉴스
Link : https://www.medipana.com/article/view.php?news_idx=332890&sch_cate=D

Article Source : 머니투데이
Link : https://news.mt.co.kr/mtview.php?no=2024092708292112737

Article Source : 머니투데이
Link : https://news.mt.co.kr/mtview.php?no=2024091209573041228

Article Source : 의학신문
Link : http://www.bosa.co.kr/news/articleView.html?idxno=2225120

Article Source : 약업신문
Link : https://www.yakup.com/news/index.html?mode=view&cat=12&nid=295583

Article Source : 한국경제
Link : https://www.hankyung.com/article/202405274631i

Article Source : 약업신문
Link : https://www.yakup.com/news/index.html?mode=view&cat=12&nid=294647

Article Source : 머니투데이
Link : https://news.mt.co.kr/mtview.php?no=2024052210221156176

Article Source : 머니투데이
Link : https://news.mt.co.kr/mtview.php?no=2024052113254369895

Article Source : BusinessWire
Link : https://www.businesswire.com/news/home/20240521344307/en/Qurient-Therapeutics-Enters-CRADA-with-the-National-Cancer-Institute-to-Collaborate-on-a-Phase-12-Clinical-Study-of-Q901-in-Combination-with-TROP2-ADC

Article Source : 뉴스핌
Link : https://www.newspim.com/news/view/20240425000691

Article Source : 약업신문
Link : https://www.yakup.com/news/index.html?mode=view&cat=12&nid=293023

Article Source : 약업신문
Link : https://www.yakup.com/news/index.html?mode=view&cat=12&nid=292917

Article Source : 뉴스핌
Link : https://www.newspim.com/news/view/20240313000253